Citation

Soth MJ, Le K, Di Francesco ME, Hamilton MM, Liu G, Burke JP, Carroll CL, Kovacs JJ, Bardenhagen JP, Bristow CA, Cardozo M, Czako B, de Stanchina E, Feng N, Garvey JR, Gay JP, Do MKG, Greer J, Han M, Harris A, Herrera Z, Huang S, Giuliani V, Jiang Y, Johnson SB, Johnson TA, Kang Z, Leonard PG, Liu Z, McAfoos T, Miller M, Morlacchi P, Mullinax RA, Palmer WS, Pang J, Rogers N, Rudin CM, Shepard HE, Spencer ND, Theroff J, Wu Q, Xu A, Yau JA, Draetta G, Toniatti C, Heffernan TP, Jones P.: Discovery of IPN60090, a Clinical Stage Selective Glutaminase-1 (GLS-1) Inhibitor with Excellent Pharmacokinetic and Physicochemical Properties. J Med Chem, Volume 63 (21), 2020

Authors

Bardenhagen JP, Bristow CA, Burke JP, Cardozo M, Carroll CL, Czako B, de Stanchina E, Di Francesco ME, Do MKG, Feng N, Garvey JR, Gay JP, Greer J, Hamilton MM, Han M, Harris A, Kovacs JJ, Le K, Liu G, Soth MJ, Draetta G, Giuliani V, Heffernan TP, Herrera Z, Huang S, Jiang Y, Johnson SB, Johnson TA, Jones P., Kang Z, Leonard PG, Liu Z, McAfoos T, Miller M, Morlacchi P, Mullinax RA, Palmer WS, Pang J, Rogers N, Rudin CM, Shepard HE, Spencer ND, Theroff J, Toniatti C, Wu Q, Xu A, Yau JA

Journal

J Med Chem

Year

2020

DOI

10.1021/acs.jmedchem.0c01398

PubMed

33118821

Machine-readable

REST APIRDF